BADS: Behavioural Assessment of the Dysexecutive Complete Kit
BADS: Behavioural Assessment of the Dysexecutive Syndrome for Evaluating Executive Function
The Behavioural Assessment of the Dysexecutive Syndrome (BADS) is a powerful, standardized tool used to evaluate executive functions in individuals experiencing cognitive difficulties due to frontal lobe damage or related neurological conditions. Designed to reflect real-life challenges, BADS goes beyond traditional IQ or memory tests by assessing how well a person manages tasks involving planning, organisation, problem-solving, rule shifting, and strategic thinking—critical skills for everyday functioning.
BADS is especially useful for clinicians and researchers working with patients recovering from brain injuries, those with Dysexecutive Syndrome (DES), or individuals with psychiatric conditions such as schizophrenia, where executive deficits are often present.
Core Components of the BADS Battery
Each subtest in BADS mirrors common, real-world tasks, offering valuable insight into how patients function outside the clinic:
Temporal Judgement – Assesses the ability to estimate how long familiar events last.
Rule Shift Cards – Measures cognitive flexibility by requiring individuals to adapt to changing rules.
Action Program – Tests problem-solving skills through a hands-on task requiring the strategic use of provided materials.
Key Search – Evaluates strategic planning using an analogue of searching for lost keys in a field.
Zoo Map Test – Assesses route planning under both structured and unstructured conditions.
Modified Six Elements – Tests the ability to manage time and switch between tasks efficiently.
Dysexecutive Questionnaire (DEX)
Included in the BADS battery is the Dysexecutive Questionnaire (DEX), a 20-item assessment covering four key areas:
Emotional and personality changes
Motivational issues
Behavioral difficulties
Cognitive dysfunctions
This self-report and observer-rated tool provides a fuller picture of how executive issues manifest in daily life.
Clinical Validation and Application
BADS is validated for use with a variety of neurological and psychiatric populations. It is particularly effective in identifying executive dysfunction in patients with brain injury and has been used in studies involving schizophrenia. Its real-world relevance makes it a crucial component in rehabilitation planning, helping clinicians tailor interventions to each individual’s unique challenges.
Explore our full range of trusted assessments to support every stage of development – click here to discover more.
Price (excl. VAT):
€728.40
